Physician profile
Wayne Riskin
NPI 1366536708
$15,932.57
in general payments reported to CMS, 2019-2025
37 companies · $2,157 in 2025
The $2,157 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,971 · 2020: $2,290 · 2021: $2,728 · 2022: $2,395 · 2023: $2,152 · 2024: $1,240 · 2025: $2,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,548.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,734.25 | 2019-2025 | Rinvoq, Skyrizi |
| Amgen INC. | $2,188.58 | 2019-2025 | Enbrel, Tavneos, Prolia |
| Mallinckrodt Hospital Products INC. | $1,794.14 | 2020-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $1,547.44 | 2019-2025 | |
| Ucb, INC. | $914.07 | 2019-2025 | Bimzelx, Cimzia |
| Glaxosmithkline, LLC. | $771.57 | 2019-2025 | Benlysta |
| Pfizer INC. | $723.58 | 2019-2025 | |
| Lilly USA, LLC | $601.73 | 2019-2025 | Taltz |
| Janssen Biotech, INC. | $597.81 | 2019-2025 | Tremfya, Simponi Aria |
| Radius Health, INC. | $531.41 | 2019-2025 | Tymlos |
| Horizon Therapeutics Plc | $509.08 | 2019-2023 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $407.63 | 2021-2024 | Saphnelo |
| Ani Pharmaceuticals, INC. | $316.03 | 2022-2025 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $273.96 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $255.48 | 2019-2025 | Orencia |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Riskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.